Israel conflict unlikely to impact trade of pharma firms

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Photograph: Yves Herman/Reuters Rising crude prices and export shipping insurance......

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country’s largest pharmaceutical (pharma) company, Sun......

Sun Pharma's growth prospects look healthy; analysts positive on the stock

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a......

Markets reel under shell firm order, Sensex at 3-week low

Healthcare, auto and financial stocks lagged. Illustration: Uttam Ghosh/Rediff.com It was the third straight session of loss for stocks on Wednesday as the Sensex took a hit of 216 points to close......